EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Phase Separation and Prion‐Like Aggregation of p53 Family Tumor Suppressors: From Protein Evolution to Cancer Treatment

Jerson L Silva iD, Guilherme C de Andrade, Elaine C Petronilho, Gileno Dos S de Sousa, Michelle F Mota, Julia Quarti, Francisca H Guedes-da-Silva, Giulia D S Ferretti, Luciana P Rangel, Tuane C R G Vieira, Mayra A Marques, Guilherme A P de Oliveira iD

Journal of Neurochemistry · 2025

DOI: 10.1111/jnc.70055 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neurochemistry, 2025. Verfasst von Jerson L Silva und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Biochemistry Leopoldo de Meis, National Institute of Science and Technology for Structural Biology and Bioimaging, National Cent…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Neoplasms, Prions, Tumor Suppressor Proteins. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 123 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biomolecular condensates, formed through phase separation (PS), are essential in various physiological processes, but they can also transition into amyloid‐like structures, contributing to diseases like cancer and neurodegenerative disorders. This review centers on the tumor suppressor protein p53 and its paralogs, p63 and p73, which play significant roles in cancer biology. Mutations in the TP53 gene, present in over half of all malignant tumors, disrupt the function of p53 and contribute to cancer progression. Mutant p53 not only misfolds but also forms biomolecular condensates and amyloid‐like aggregates, like the toxic amyloids seen in neurodegenerative diseases. These amyloid‐like structures, characteristic of mutant p53, might be associated with its gain of function (GoF) in cancer. Recent in vitro and in cell studies demonstrate that mutant p53 can exert a prion‐like effect on its paralogs, p63 and p73, which typically do not form amyloids under physiological conditions. Heparin inhibits the prion‐like effect of mutant p53 on p63 and p73. These findings underscore the critical role of mutant p53 in promoting the aggregation of p63 and p73, and likely of other transcription factors, suggesting new therapeutic targets. The amyloid‐like aggregation of mutant p53 is an excellent candidate target for cancer, as evidenced by recent studies. By understanding the phase transitions and amyloid formation of mutant p53, innovative diagnostic and treatment strategies have been explored to reveal and disrupt these processes, offering hope for improved cancer therapies. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53NeoplasmsPrionsTumor Suppressor ProteinsHumansAnimalsTumor Protein p73Protein AggregatesMutationProtein Aggregation, PathologicalPhase Separation

Stichwörter der Autor:innen

biomolecular condensatescancerp53phase separationprion diseasesprotein aggregation

Substanzen

Tumor Suppressor Protein p53PrionsTumor Suppressor ProteinsTumor Protein p73Protein Aggregates

Autor:innen und Institutionen

  • Institute of Medical Biochemistry Leopoldo de Meis, National Institute of Science and Technology for Structural Biology and Bioimaging, National Center of Nuclear Magnetic Resonance Jiri Jonas, Federal University of Rio…
  • National Center for Structural Biology and Bioimaging (CENABIO), Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.
  • Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID-Profile: Jerson L Silva, Guilherme A P de Oliveira

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Silva, J. L., de Andrade, G. C., Petronilho, E. C., de Sousa, G. D. S., Mota, M. F., Quarti, J., Guedes-da-Silva, F. H., Ferretti, G. D. S., Rangel, L. P., Vieira, T. C. R. G., Marques, M. A., & de Oliveira, G. A. P. (2025). Phase Separation and Prion‐Like Aggregation of p53 Family Tumor Suppressors: From Protein Evolution to Cancer Treatment. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70055

Vancouver

Silva JL, de Andrade GC, Petronilho EC, de Sousa GDS, Mota MF, Quarti J, et al. Phase Separation and Prion‐Like Aggregation of p53 Family Tumor Suppressors: From Protein Evolution to Cancer Treatment. Journal of Neurochemistry. 2025. doi:10.1111/jnc.70055

BibTeX
@article{Silva2025,
  author = {Silva, Jerson L and de Andrade, Guilherme C and Petronilho, Elaine C and de Sousa, Gileno Dos S and Mota, Michelle F and Quarti, Julia and Guedes-da-Silva, Francisca H and Ferretti, Giulia D S and Rangel, Luciana P and Vieira, Tuane C R G and Marques, Mayra A and de Oliveira, Guilherme A P},
  title = {Phase Separation and Prion‐Like Aggregation of p53 Family Tumor Suppressors: From Protein Evolution to Cancer Treatment},
  journal = {Journal of Neurochemistry},
  year = {2025},
  doi = {10.1111/jnc.70055}
}
Kostenlos starten →